These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Henrique R, Jerónimo C. Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280 [Abstract] [Full Text] [Related]
23. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW. Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492 [Abstract] [Full Text] [Related]
24. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ. Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747 [Abstract] [Full Text] [Related]
25. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM. Mol Cell Probes; 2000 Aug 01; 14(4):211-7. PubMed ID: 10970725 [Abstract] [Full Text] [Related]
26. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. Kang GH, Lee S, Lee HJ, Hwang KS. J Pathol; 2004 Feb 01; 202(2):233-40. PubMed ID: 14743506 [Abstract] [Full Text] [Related]
27. Gene promoter methylation in prostate tumor-associated stromal cells. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG. J Natl Cancer Inst; 2006 Feb 15; 98(4):255-61. PubMed ID: 16478744 [Abstract] [Full Text] [Related]
28. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens. Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL. Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431 [Abstract] [Full Text] [Related]
29. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D. J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165 [Abstract] [Full Text] [Related]
30. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M. Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910 [Abstract] [Full Text] [Related]
31. Methylation-specific PCR for detection of neoplastic DNA in biopsy washings. Goessl C, Müller M, Heicappell R, Krause H, Schostak M, Straub B, Miller K. J Pathol; 2002 Mar 01; 196(3):331-4. PubMed ID: 11857497 [Abstract] [Full Text] [Related]
32. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A. Urology; 2008 Jan 01; 71(1):161-7. PubMed ID: 18242387 [Abstract] [Full Text] [Related]
33. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Qiu G, Fang J, He Y. Clin Biochem; 2006 Mar 01; 39(3):259-66. PubMed ID: 16516880 [Abstract] [Full Text] [Related]
34. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Stirzaker C, Song JZ, Davidson B, Clark SJ. Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996 [Abstract] [Full Text] [Related]
35. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas]. Wang JH, Qin Y, Li B, Sun ZL, Sun ZF, Guan QL. Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep 01; 36(5):686-8. PubMed ID: 16235538 [Abstract] [Full Text] [Related]
36. Quantification of methylated DNA by HeavyMethyl duplex PCR. Distler J. Methods Mol Biol; 2009 Sep 01; 507():339-46. PubMed ID: 18987825 [Abstract] [Full Text] [Related]
37. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Crocitto LE, Korns D, Kretzner L, Shevchuk T, Blair SL, Wilson TG, Ramin SA, Kawachi MH, Smith SS. Urology; 2004 Oct 01; 64(4):821-5. PubMed ID: 15491741 [Abstract] [Full Text] [Related]
38. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O. Clin Cancer Res; 2007 Mar 15; 13(6):1720-5. PubMed ID: 17363525 [Abstract] [Full Text] [Related]
39. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Lin X, Nelson WG. Cancer Res; 2003 Jan 15; 63(2):498-504. PubMed ID: 12543808 [Abstract] [Full Text] [Related]
40. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS. Prostaglandins Other Lipid Mediat; 2007 Jan 15; 82(1-4):185-97. PubMed ID: 17164146 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]